Chronic Pain — 18 February 2013

imagesBy Pat Anson, Editor

A bipartisan group of congressmen is demanding the Food and Drug Administration “act without delay” by restricting access to Vicodin and other hydrocodone products, the most widely used and abused narcotic painkiller in the U.S.

Last month an advisory panel to the FDA voted 19 to 10 to reclassify hydrocodone products from a Schedule III controlled substance to a Schedule II drug, which will make it harder for pain patients to obtain or get refills for. The FDA, which usually follows the recommendations of its advisory panels, has not yet made a final decision on the matter.

Read more at National Pain Report.

Share

About Author

Pat Anson, Editor

Pat is Editor in Chief of American News Report. He is a veteran journalist and a former correspondent and producer for HealthWeek (PBS), Nightly Business Report (PBS) and other nationally syndicated shows. Pat has won numerous journalism awards, including a Golden Mike award for investigative reporting.

(0) Readers Comments

Comments are closed.